These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3898986)

  • 1. Galloway memorial lecture. Platelet injury and antithrombin III in clinical nephrology.
    Woo KT
    Ann Acad Med Singap; 1985 Apr; 14(2):394-403. PubMed ID: 3898986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets.
    Woo KT; Wei SS; Lee EJ; Lau YK; Lim CH
    Nephron; 1985; 40(1):25-8. PubMed ID: 4000334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III in mesangial IgA nephritis.
    Woo KT; Lee EJ; Lau YK; Lim CH
    Thromb Res; 1985 Nov; 40(4):483-7. PubMed ID: 4082121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy with crescents in kidney transplant recipients.
    Kowalewska J; Yuan S; Sustento-Reodica N; Nicosia RF; Smith KD; Davis CL; Alpers CE
    Am J Kidney Dis; 2005 Jan; 45(1):167-75. PubMed ID: 15696457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Lai KN; Yin JA; Yuen PM; Li PK
    Nephron; 1990; 56(3):271-6. PubMed ID: 2150218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased reticulated platelets in dialysis patients.
    Himmelfarb J; Holbrook D; McMonagle E; Ault K
    Kidney Int; 1997 Mar; 51(3):834-9. PubMed ID: 9067918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of coagulation and platelet functions in heparin-free hemodialysis.
    Ivanovich P; Xu CG; Kwaan HC; Hathiwala S
    Nephron; 1983; 33(2):116-20. PubMed ID: 6835458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerulonephritis in Singapore: an overview.
    Woo KT; Chiang GS; Edmondson RP; Wu AY; Lee EJ; Pwee HS; Lim CH
    Ann Acad Med Singap; 1986 Jan; 15(1):20-31. PubMed ID: 3707031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure.
    Langley PG; Keays R; Hughes RD; Forbes A; Delvos U; Williams R
    Hepatology; 1991 Aug; 14(2):251-6. PubMed ID: 1860682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin in mesangial IgA nephropathy.
    Woo KT; Tan YO; Yap HK; Lau YK; Tay JS; Lim CH
    Nephron; 1984; 37(2):78-81. PubMed ID: 6374483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis.
    Tàssies D; Reverter JC; Cases A; Escolar G; Villamor N; López-Pedret J; Castillo R; Ordinas A
    Am J Hematol; 1995 Nov; 50(3):161-6. PubMed ID: 7485076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on platelet function of hypoalbuminemia in peritoneal dialysis.
    Sloand EM; Bern MM; Kaldany A
    Thromb Res; 1986 Nov; 44(4):419-25. PubMed ID: 3798407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin-III and platelets in haemodialysis patients.
    Brandt P; Jespersen J; Sørensen LH
    Nephron; 1981; 28(1):1-3. PubMed ID: 7266723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III in renal transplant recipients.
    Woo KT; Lee EJ; Lau YK; Lim CH
    Thromb Res; 1985 May; 38(3):201-6. PubMed ID: 3895560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and antithrombin III in uraemia: the acute effect of haemodialysis.
    Knudsen F; Dyerberg J
    Scand J Clin Lab Invest; 1985 Jun; 45(4):341-7. PubMed ID: 3160101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Focal segmental glomerulosclerosis after renal transplantation in a child with ANCA-associated glomerulonephritis: case report and literature review].
    Rong LP; Chen LZ; Fu Q; Chen WF; Sun LZ; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):936-940. PubMed ID: 27938596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.